PS01.58: A Phase 3 Trial of Nivolumab, Nivolumab Plus Ipilimumab, or Placebo Maintenance for Extensive-Stage SCLC After First-Line Chemotherapy: Topic: Medical Oncology.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_31B1D8DEDCC4
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
PS01.58: A Phase 3 Trial of Nivolumab, Nivolumab Plus Ipilimumab, or Placebo Maintenance for Extensive-Stage SCLC After First-Line Chemotherapy: Topic: Medical Oncology.
Journal
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Author(s)
Owonikoko T., Ready N., Postmus P., Reck M., Peters S., Pieters A., Selvaggi G., Fairchild J., Govindan R.
ISSN
1556-1380 (Electronic)
ISSN-L
1556-0864
Publication state
Published
Issued date
11/2016
Peer-reviewed
Oui
Volume
11
Number
11S
Pages
S306-S307
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
OAI-PMH
oai:serval.unil.ch:BIB_31B1D8DEDCC4
DOI
10.1016/j.jtho.2016.09.093
Pubmed
27969525
Create date
21/12/2016 14:47
Last modification date
21/08/2019 5:37
Usage data